1. OP0045 DELINEATION OF A PROINFLAMMATORY CYTOKINE PROFILE TARGETED BY JAK1/2 INHIBITION USING BARICITINIB IN A PHASE 2 SLE TRIAL. (2nd June 2020) Authors: Dörner, T.; Tanaka, Y.; Petri, M. A.; Smolen, J. S.; Wallace, D.; Crowe, B.; Dow, E.; Higgs, R. E.; Rocha, G.; Benschop, R.; Silk, M.; De Bono, S.; Hoffman, R.; Fantini, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗